Metis Global Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Metis Global Partners's JNJ Position: Q2 2026 in Review
Metis Global Partners reduced its Johnson & Johnson (JNJ) stake by 9.4% in Q2 2026, selling an estimated $2.25M and leaving 93,168 shares worth $23.7M. The position accounts for 0.54% of the portfolio, ranked #30.
Metis Global Partners first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. The position peaked at $25.9M in Q1 2025. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Metis Global Partners held 93,168 shares of Johnson & Johnson worth $23.7M as of Q2 2026.
- Metis Global Partners sold 9,644 Johnson & Johnson shares in Q2 2026, an estimated $2.25M.
- Johnson & Johnson made up 0.54% of Metis Global Partners's portfolio in Q2 2026, its #30 holding.
- Metis Global Partners first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
- Metis Global Partners's Johnson & Johnson position peaked at $25.9M in Q1 2025.
- 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.